POZ news story
DoxyPEP is becoming less effective against gonorrhea as antibiotic resistance rises, even as protection against chlamydia and syphilis remains durable, according to study results published in The Lancet Infectious Diseases.
“We report a rapid loss of effectiveness of doxycycline PEP for prevention of gonorrhea in male individuals living with HIV or receiving HIV PrEP or PEP in Southern California,” the authors wrote, noting that their findings might merit revision of guidelines recommending doxyPEP for gonorrhea prevention.
Read the full news story here.
SEE ALSO:
Source : POZ
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.